134 related articles for article (PubMed ID: 9247102)
1. Expression of c-Myc, TGF-alpha and EGF-receptor in sporadic medullary thyroid carcinoma.
Wang W; Johansson HE; Bergholm UI; Westermark KM; Grimelius LE
Acta Oncol; 1997; 36(4):407-11. PubMed ID: 9247102
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
Int J Cancer; 1993 Aug; 55(1):37-43. PubMed ID: 8102129
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels.
Khosla S; Oursler MJ; Schroeder MJ; Eberhardt NL
Endocrinology; 1994 Nov; 135(5):1887-93. PubMed ID: 7956909
[TBL] [Abstract][Full Text] [Related]
5. The autocrine loop of epidermal growth factor receptor-epidermal growth factor / transforming growth factor-alpha in malignant rhabdoid tumor cell lines: heterogeneity of autocrine mechanism in TTC549.
Narita T; Taga T; Sugita K; Nakazawa S; Ohta S
Jpn J Cancer Res; 2001 Mar; 92(3):269-78. PubMed ID: 11267936
[TBL] [Abstract][Full Text] [Related]
6. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
7. Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors.
Gorgoulis V; Aninos D; Priftis C; Evagelopoulou C; Karameris A; Kanavaros P; Spandidos DA
In Vivo; 1992; 6(3):291-6. PubMed ID: 1391697
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-alpha) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status.
Umekita Y; Enokizono N; Sagara Y; Kuriwaki K; Takasaki T; Yoshida A; Yoshida H
Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):345-51. PubMed ID: 1348890
[TBL] [Abstract][Full Text] [Related]
9. Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.
Yoshida K; Kuniyasu H; Yasui W; Kitadai Y; Toge T; Tahara E
J Cancer Res Clin Oncol; 1993; 119(7):401-7. PubMed ID: 8491760
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
Reinartz JJ; George E; Lindgren BR; Niehans GA
Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of the EGF receptor system in human thyroid neoplasia.
Lemoine NR; Hughes CM; Gullick WJ; Brown CL; Wynford-Thomas D
Int J Cancer; 1991 Oct; 49(4):558-61. PubMed ID: 1917156
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer.
Thøgersen VB; Jørgensen PE; Sørensen BS; Bross P; Orntoft T; Wolf H; Nexø E
Scand J Clin Lab Invest; 1999 Jul; 59(4):267-77. PubMed ID: 10463465
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma.
Roncalli M; Viale G; Grimelius L; Johansson H; Wilander E; Alfano RM; Springall D; Battezzati PM; Polak JM; Coggi G
Cancer; 1994 Jul; 74(1):134-41. PubMed ID: 7911734
[TBL] [Abstract][Full Text] [Related]
14. Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.
Mórocz IA; Schmitter D; Lauber B; Stahel RA
Br J Cancer; 1994 Nov; 70(5):850-6. PubMed ID: 7947089
[TBL] [Abstract][Full Text] [Related]
15. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis.
Shi Y; Zou M; Farid NR
Clin Endocrinol (Oxf); 1993 Sep; 39(3):269-74. PubMed ID: 8222289
[TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid.
Beenken SW; Sellers MT; Huang P; Peters G; Krontiras H; Dixon P; Stockard C; Listinsky C; Grizzle WE
Head Neck; 1999 Sep; 21(6):566-73. PubMed ID: 10449674
[TBL] [Abstract][Full Text] [Related]
18. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of transforming growth factors in human breast cancer.
Murray PA; Barrett-Lee P; Travers M; Luqmani Y; Powles T; Coombes RC
Br J Cancer; 1993 Jun; 67(6):1408-12. PubMed ID: 8390290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
